Tobira Therapeutics

Get Full Access

Description

  • Tobira is focused on developing and commercializing innovative therapeutics to treat liver disease, human immunodeficiency virus, or HIV-1, fibrosis and inflammation. Its lead product candidate, cenicriviroc, or CVC, is a proprietary immunomodulator that may be used to treat a number of diseases, including NASH, kidney fibrosis, HIV-1 and others. Tobiras management team has extensive experience in developing and commercializing therapeutics for liver disease and HIV-1.The lead indication for CVC is non-alcoholic steatohepatitis, or NASH, for which Tobira plans to begin a Phase 2 clinical trial in the second half of 2014. The company believes there are no other product candidates in development for NASH that target the immuno-inflammatory pathways responsible for fibrosis.CVC also is Phase 3-ready in HIV-1 infection with potential as the backbone in a fixed-dose combination therapy. CVC is a once-daily pill with a safety and tolerability profile that has been established to date in 550 subjects dosed in completed Phase 1 and Phase 2 trials, including 115 HIV-1 infected subjects on treatment for up to 48 weeks.
  • location

    Headquarters:701 Gateway Boulevard Suite 300, South San Francisco, California, United States

    More
  • Tobira Therapeutics phone

    Phone Number: +1 650-741-6625

  • Tobira Therapeutics website

    Website: https://www.tobiratherapeutics.com

  • Tobira Therapeutics employees

    Employees:6

  • Tobira Therapeutics revenue

    Revenue:$1 - 10M

  • Tobira Therapeutics legal name

    Legal Name:Tobira Therapeutics

  • Tobira Therapeutics's Social Media

    Tobira Therapeutics linkedin
  • done Is this data correct?
  • |  NAICS Code: 621399  |

    Show More
Person level website identification

Director, Quality Assurance for Tobira Therapeutics

Cliff Sachs

Director, Quality Assurance

Person level website visitor identification

Sell more in less time!

Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

View Employees

Cliff Sachs

Director, Quality Assurance

Frequently Asked Questions regarding Tobira Therapeutics

  • Where are Tobira Therapeutics's Headquarters?

    Tobira Therapeutics's Headquarters are in 701 Gateway Boulevard Suite 300,South San Francisco,California,United States

  • What is Tobira Therapeutics's phone number?

    Tobira Therapeutics's phone number is +1 650-741-6625

  • What is Tobira Therapeutics's official website?

    Tobira Therapeutics's official website is https://www.tobiratherapeutics.com

  • What is Tobira Therapeutics's Revenue?

    Tobira Therapeutics's revenue is $1 - 10M

  • What is Tobira Therapeutics's NAICS code?

    Tobira Therapeutics's NAICS code is 621399

  • How many employees are working in Tobira Therapeutics

    Tobira Therapeutics has 6 employees

  • What is Tobira Therapeutics's Industry?

    Tobira Therapeutics is in the industry of Biotechnology

  • Who is Tobira Therapeutics's Director, Quality Assurance?

    Tobira Therapeutics's Director, Quality Assurance is Cliff Sachs

Company Directory